Marijuana and Nicotine Vaping Prevention Videogame Coming to Three CT Middle Schools
A top public health concern among today’s adolescents is the widespread use of nicotine and marijuana vaping devices. Now, two researchers at Yale School of Medicine, Kimberly Hieftje, PhD, and Deepa Camenga, MD, MHS, are teaming up with the Connecticut Department of Public Health (DPH) to bring a classroom-based virtual reality (VR) nicotine and marijuana vaping prevention videogame to students in three Connecticut middle schools.
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.
Addiction Medicine Fellowship Training at Yale Expands To Advanced Practice Providers
Yale School of Medicine established an addiction medicine fellowship program for advanced practice providers, including physician assistants and advanced practice registered nurses as part of the Substance Use Skills Training to Advance INtegrated care project.
Opara receives $3.5 million grant to curb urban drug use, involve youth in research
Yale School of Public Health Associate Professor Ijeoma Opara has received the NIDA (National Institute on Drug Abuse) Racial Equity Visionary Award. The award is a NIDA DP1 grant for $3.5 million over five years that will allow her to work within predominantly urban neighborhoods to curb substance use among racial/ethnic minorities.
Highlighting Gender-based Differences in Alcohol-associated Hepatitis
During her Yale School of Medicine fellowships in gastroenterology and transplant hepatology, Anahita Rabiee, MD, MHS, instructor of medicine (digestive diseases), saw a lot of men and women admitted with alcohol-associated hepatitis—the most severe form of alcohol-related liver disease—at Yale New Haven Hospital. At the time, she couldn’t help noticing that women with this condition tended to have worse outcomes than men.
Ukrainian Refugees Face High Barriers to Opioid Use Disorder Treatment, Yale Study Finds
Many Ukrainian refugees fleeing the war have encountered obstacles when seeking therapies for opioid use disorder in European Union countries, a new Yale-led study finds. The study examines the barriers to opioid agonist therapies (OAT) and providers’ responses to increased demand in OAT enrollment.
The Importance of Considering Sex and Gender in Tobacco Regulation
In a recent JAMA Viewpoint, three Yale Psychiatry faculty members showcase why a greater focus on sex and gender differences in FDA regulatory action on tobacco is essential to public health. They highlight specific tobacco regulations under consideration by FDA and offer approaches as to how the impact of sex and gender can be integrated into regulatory actions.
Saving Lives: YSPH students receive training on overdose response
On February 9th, 2023, 91 Yale School of Public Health students gathered in Winslow Auditorium for training on overdose prevention and response. Overdose training is considered an important skill for future public health practitioners and community workers.
Survey Shows Most Physicians Favor Allowing Telehealth to Treat Opioid-use Disorder
A survey of more than 1,000 registered physicians who used telehealth services to treat patients with opioid-use disorder during COVID-19 found that an overwhelming majority favor making telehealth a permanent part of their practice.
De Aquino Awarded IMPOWR-YOU Grant to Study Pain Sensitivity, Opioid Use Disorder
Joao P. De Aquino, MD, assistant professor of psychiatry, has been awarded a pilot grant from the Integrative Management of Chronic Pain and Opioid Use Disorder for Whole Recovery-Yale and Organizations United (IMPOWR-YOU) Research Center to evaluate the relationship between pain sensitivity and brain synaptic density among people with opioid use disorder (OUD).
Yale Scientists Identify Genetic Risk Factors for Opioid Use and Related Substance Use Disorders
A new human genomics study led by Yale scientists has identified genetic risk factors for opioid use disorder (OUD) and related substance use disorders according to a new large-scale genome-wide association study – increasing the number of risk genes known from 1 to 19.
Le Zhang, PhD Wins Avenir Award for Research on Substance Use Disorders and HIV/AIDS
Assistant Professor Le Zhang, PhD was recently awarded a DP2 grant from the National Institutes of Health (NIH), entitled “Immune Network Dysregulation of the Central Nervous System with HIV Persistence and Opioid Abuse.” The grant, which amounts to more than $2.5 million, began on May 15, 2022 and lasts for four years.
Patients with Opioid Use Disorder Treated in Emergency Departments Shed Light on Their Unmet Needs and Opportunities to Improve Care in Yale-Led Study Published in JAMA Network Open
To better understand the experiences of patients with OUD on receiving care in the ED and to identify opportunities to improve care, Yale researchers led a collaboration with New York University, John’s Hopkins University, University of Cincinnati, Mount Sinai Hospital in New York, and the University of Washington. Between June 2018 and January 2019. They conducted focus groups with ED patients across six academic, community, and public safety net EDs in Baltimore, MD, Cincinnati, OH, New York City, NY, Seattle, WA and Claremont, NH, as part of two NIDA Clinical Trials Network studies.
Stressed Out and Locked-Down During Pandemic, New Yorkers Craved Alcohol, YSPH Study Finds
As New York state’s lockdown orders wore on in the early months of the COVID-19 pandemic, residents increasingly felt cravings for alcohol — and reported subsequently misusing it, a new study from scientists at the Yale School of Public Health and Stony Brook University has found.
Pandemic-based Approach to Methadone Treatment Restrictions Should Remain, YSPH Study Finds
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.